about
Assessment of Venous Thrombosis in Animal ModelsComparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-AnalysisFibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis.Blood Oxygenation Level-Dependent CMR-Derived Measures in Critical Limb Ischemia and Changes With Revascularization.Medium-Term Outcomes Following Endovascular Repair of Infrarenal Abdominal Aortic Aneurysms with an Unfavourable Proximal Neck.Changing paradigms in the management of deep vein thrombosis.Postsurgical Inflammation as a Causative Mechanism of Venous Thromboembolism.Contemporary management of acute and chronic deep venous thrombosis.Optimal diagnostics of residual stenosis after lysis.Quantification of experimental venous thrombus resolution by longitudinal nanogold-enhanced micro-computed tomography.Multi-sequence non-contrast MRI characterization of deep vein thrombosis in man.Increased vascular permeability is a surrogate marker of atherosclerotic plaque instability.Deviation.After the cure.Radiation-Induced DNA Damage in Operators Performing Endovascular Aortic Repair.Human venous valve disease caused by mutations in FOXC2 and GJC2.Increased Vascular Permeability Measured With an Albumin-Binding Magnetic Resonance Contrast Agent Is a Surrogate Marker of Rupture-Prone Atherosclerotic Plaque.Cancer-Associated Thrombosis: Regulatory Mechanisms and Emerging Directions.The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers.Antiangiogenic therapy inhibits venous thrombus resolution.Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation.TNF-α (Tumor Necrosis Factor-α)Endovascular Therapy for Central Venous ThrombosisUse of Computed Tomography and Magnetic Resonance Imaging in Central Venous DiseaseRegulation of sterile inflammation in the natural resolution of venous thrombosisLocal accumulation of hypoxia-inducible factor 2 alpha during venous thrombus resolutionResponse by Patel et al to Letter Regarding Article, "Radiation Induced DNA Damage in Operators Performing Endovascular Aortic Repair"Paget-Schroetter syndrome: A contemporary review of the controversies in managementRedox dysregulation in the pathogenesis of chronic venous ulcerationInhibition of prolyl hydroxylase domain proteins selectively enhances venous thrombus neovascularisationTwo Year Outcome After Chronic Iliac Vein Occlusion Recanalisation Using the Vici Venous Stent®Tropoelastin: A novel marker for plaque progression and instabilityChoosing a Mouse Model of Venous ThrombosisMidterm outcomes in postpartum women following endovenous treatment for acute iliofemoral deep vein thrombosisChoosing a mouse model of venous thrombosis: a consensus assessment of utility and applicationThe superior doctor
P50
Q26774967-98389086-4C32-41B4-95E0-1A389B640B5CQ26798134-38E78816-7834-413C-88CE-1489F1122308Q34333548-744A991A-4445-4271-BF68-69D077CA4212Q36506159-AEC4D442-0787-4A5C-AECB-7AFDDA6894D1Q38299363-7A212E13-DA5B-4303-BDEE-CF6B04EA7906Q38429103-1280C290-94A9-44CD-8DC2-F7847F94B184Q38567316-DCD78AA8-2952-480D-8D3D-4AFACC837CDDQ38740345-653607A0-756C-499A-A275-BA6CDAADD40DQ38750729-540BE630-6D28-4E86-94C2-0DED7BC97464Q40405876-CA712082-693D-4F21-9E1C-82EA7208FF43Q45801706-1E34AC62-56E8-49F6-A859-D467648A982BQ46491732-0E30F7C1-8CF4-4364-B55A-43766DDC7E78Q47100887-8858A2B0-CC78-4120-A857-DA0FE189C744Q47147224-2E98D89A-7E3E-4C75-8C9D-03E556CF320AQ47621798-EBE8F463-BFF6-4186-96DC-9AAE50A40A24Q48099591-226017E5-8979-4609-BBE0-1AB287D56BA7Q51017688-FEE50ED8-15D2-4027-AE84-043FA0A69686Q51496815-9F87E594-DA68-490F-934E-F12A1B1CC895Q52879755-6CDC34F6-24B4-4BE2-92AB-F4220330676DQ53072354-05248E56-87E5-4716-9C5A-0A6DCB2E3AE3Q55082789-21E52274-BA31-4A0E-B72B-7E44E32AA43DQ57786770-11A1F381-74DC-4B0A-9E6C-AC89809D94FDQ58571084-E69FF09E-CE71-4AB0-9766-C40265941446Q58571115-BF09BDBA-A47E-46CA-9940-652516A978E0Q86415821-E1640E22-DE5B-4EE9-B8C7-5C6E42E4F7FDQ87492515-7DD1D535-4C36-4E29-B314-3EFCF774DE70Q89068833-1993F858-0F38-4023-B5C2-D78BDFE2887EQ89579152-D40DABDF-0A01-42F2-9259-8673EE0679D0Q90331145-ED877831-1403-4378-A9E0-A78161FF2BE7Q90381821-4E81E462-9A7D-48E5-930D-74C0DEF15823Q91112003-8AC339B3-11CD-4826-BBA4-05D82ED62712Q91439798-AA1BCCAD-BDF3-42DA-AFC0-C5A439809BBEQ91754400-5780D7D4-5488-4B03-A173-C6820ACAFDC7Q92265419-377275F1-395F-4481-BF5A-1BB7A67238C8Q92711238-4D98329B-F48A-4FCE-AB6C-178583982F58Q93531475-8DFC50DB-D575-4EC0-BE98-39E11CD93B0A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Prakash Saha
@ast
Prakash Saha
@en
Prakash Saha
@es
Prakash Saha
@nl
type
label
Prakash Saha
@ast
Prakash Saha
@en
Prakash Saha
@es
Prakash Saha
@nl
prefLabel
Prakash Saha
@ast
Prakash Saha
@en
Prakash Saha
@es
Prakash Saha
@nl
P106
P31
P496
0000-0002-9591-1063